BoomRx ordering platform explained

Compounded and manufactured medications for cash-pay clinics move through a defined stack: the prescriber writes the order, a procurement platform routes it, a licensed pharmacy makes or sources it, and a carrier ships it to the patient. The BoomRx ordering platform occupies the second step — the routing and coordination layer. It is the interface and logic that turns a clinic's selection into an order the right partner pharmacy can fulfill.

Because the platform is the routing layer and not the pharmacy, its responsibilities are catalog, ordering, submission, shipping coordination, and status — not compounding or physical fulfillment. That boundary is why pricing visibility, patient-linked checkout, and per-line audit are the meaningful ways to evaluate the platform itself, separate from the quality of the partner pharmacies.

The BoomRx ordering platform controls how a clinic experiences procurement: how the catalog is browsed, how orders are submitted, how the $30 flat-rate shipping fee is applied, and how status is surfaced. BoomRx also advertises real-time order tracking, automated SMS delivery updates for patients, live-time data reporting, and EMR and API integrations at this layer. What it does not control is the compounding, the certificates of analysis, the fill times, or the state licensure — those depend on the 503A and 503B partner pharmacies the platform routes to.

This is where ordering platforms differ from one another. Fizy Health operates at the same layer but shows pass-through per-vial 503A cost on each catalog and cart line before checkout, validates SIGs and prescriber licensure before payment, and ties every cart line to a patient with HIPAA audit. The pharmacy network is comparable on 503A; the platform behavior — procurement-first versus patient-linked — is the wedge.